EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

Effect of Neoadjuvant Hormonal Therapy on Breast Conservation in Invasive Ductal Versus Lobular Carcinoma of the Breast: A Comparative Analysis

Nicole H Goldhaber iD, Thomas J O'Keefe, Lauren Longo, Sarah L Blair, Sara Grossi

Journal of Surgical Oncology · 2025

DOI: 10.1002/jso.70082 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Surgical Oncology, 2025. Verfasst von Nicole H Goldhaber und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of California San Diego Health, La Jolla, California, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Carcinoma, Lobular, Neoadjuvant Therapy, Carcinoma, Ductal, Breast. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Comparative efficacy of neoadjuvant hormonal therapy in downstaging invasive ductal carcinoma (IDC) versus invasive lobular carcinoma (ILC) remains an area of uncertainty and may impact primary breast conservation rates.

Methods

The National Cancer Database was used to identify women with IDC and ILC who underwent neoadjuvant hormonal therapy alone between 2004 and 2020. Clinical and pathological T‐staging were examined and patients that downstaged before surgery were identified. Univariate and multivariate comparison analyses were performed. The effect of duration of neoadjuvant hormonal therapy was also examined.

Results

Among women with IDC, 39.5% had lesions that downstaged compared to 30.0% with ILC ( p < 0.001). Overall, the duration of neoadjuvant hormonal therapy was longer in patients with downstaged lesions compared to those that did not (mean = 126.9 v 99.4 days; p < 0.001). Of those who downstaged, 43% of patients with IDC and 57.8% of patients with ILC underwent mastectomy following neoadjuvant hormonal therapy.

Conclusions

Overall, ILC lesions are less likely to downstage after neoadjuvant hormonal therapy alone compared to IDC lesions. In both histologic subtypes, cancers were more likely to downstage after over 120 days of neoadjuvant hormonal therapy. Clinicians should be mindful when counseling patients that neoadjuvant hormonal therapy alone may not preclude the need for mastectomy in ILC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCarcinoma, LobularNeoadjuvant TherapyCarcinoma, Ductal, BreastAntineoplastic Agents, HormonalMastectomy, SegmentalHumansFemaleMiddle AgedAgedAdultRetrospective StudiesFollow-Up StudiesMastectomy

Stichwörter der Autor:innen

breast cancerbreast conservationhormonal therapylobular carcinomaneoadjuvant

Substanzen

Antineoplastic Agents, Hormonal

Autor:innen und Institutionen

  • Department of Surgery, University of California San Diego Health, La Jolla, California, USA.
  • School of Medicine, University of California San Diego, La Jolla, California, USA.

ORCID-Profile: Nicole H Goldhaber

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Goldhaber, N. H., O'Keefe, T. J., Longo, L., Blair, S. L., & Grossi, S. (2025). Effect of Neoadjuvant Hormonal Therapy on Breast Conservation in Invasive Ductal Versus Lobular Carcinoma of the Breast: A Comparative Analysis. Journal of Surgical Oncology. https://doi.org/10.1002/jso.70082

Vancouver

Goldhaber NH, O'Keefe TJ, Longo L, Blair SL, Grossi S. Effect of Neoadjuvant Hormonal Therapy on Breast Conservation in Invasive Ductal Versus Lobular Carcinoma of the Breast: A Comparative Analysis. Journal of Surgical Oncology. 2025. doi:10.1002/jso.70082

BibTeX
@article{Goldhaber2025,
  author = {Goldhaber, Nicole H and O'Keefe, Thomas J and Longo, Lauren and Blair, Sarah L and Grossi, Sara},
  title = {Effect of Neoadjuvant Hormonal Therapy on Breast Conservation in Invasive Ductal Versus Lobular Carcinoma of the Breast: A Comparative Analysis},
  journal = {Journal of Surgical Oncology},
  year = {2025},
  doi = {10.1002/jso.70082}
}
Kostenlos starten →